SICHUAN BIOKIN PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 184.8 CNY | +5.36% |
|
+1.89% | +32.11% |
| 07-04 | Biokin Pharmaceutical Enrolls First Patient in Breast Cancer Drug Trial | MT |
| 06-21 | Sichuan Biokin Pharmaceutical Co.,Ltd. to Issue Shares and List in Hong Kong | CI |
Sichuan Biokin Pharmaceutical Co Ltd is a China-based company mainly engaged in drug research and development, production and marketing. The Company is mainly engaged in two business sectors: chemical preparations and Chinese patent medicine preparations, and innovative biological medicine business. The Company's main products include propofol emulsion injection, dexmedetomidine hydrochloride injection, medium/long chain fat emulsion injection, ribavirin granules and other chemical preparations, Chaihuang granules and other Chinese patent medicine preparations. The Company mainly conducts its business in the domestic market.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
184.8
CNY
Average target price
226
CNY
Spread / Average Target
+22.28%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +32.11% | 10.2B | |
| +56.89% | 823B | |
| +39.52% | 627B | |
| -6.55% | 353B | |
| +15.99% | 320B | |
| +7.92% | 295B | |
| +13.74% | 239B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 167B |
- Stock Market
- Equities
- 688506 Stock
- News Sichuan Biokin Pharmaceutical Co.,Ltd.
- Biokin Pharmaceutical Enrolls First Patient in Breast Cancer Drug Trial
